Did you miss this year’s iwCLL 2017? Presentations available regarding state-of the-art concepts emerging from clinic-based and laboratory-based research about the pathobiology and treatment of CLL. This information is organized around the development, progression, and evolution of CLL.
To view the presentations from this iwCLL 2017, please click on individual presentations below. To access each day, please select the individual tabs organized by the workshop days.
Session 3 Role of the B-Cell Receptor and Other Signaling Pathways in CLL
Chairs: Nicholas Chiorazzi and Kostas Stamatopoulos
II: DIAGNOSIS AND INITIAL TREATMENT OF CLL
Chairs: Stephen Mulligan and Neil E. Kay
Session 4 Strategies for the Evaluation and Treatment of CLL in the Front-line Setting
|Clinical Approach to the Diagnosis and Initial Evaluation of a CLL Patient
|Presentation and discussion of revised iwCLL guidelines for the approach to a CLL patient
Session 5 Additional Considerations for the Initial Treatment of CLL
Chairs: Richard Furman and Jae Park
Please contact us at firstname.lastname@example.org for more information.